Navigation Links
Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
Date:10/18/2007

will facilitate the implementation and validation of molecular diagnostics in clinical settings, as well as close ongoing interaction between scientists and clinicians. Health care systems will benefit from newly developed diagnostics through the most cost-effective use of medical treatments, while patients and the public in general will enjoy greater overall health outcomes.

ASU President Michael Crow added that this endeavor promises to become a shining example of how multiple partners can work together to address a critical need in human health and accelerate solutions that extend beyond our own community.


'/>"/>

Contact: Galen Perry
gperry@tgen.org
602-343-8423
The Translational Genomics Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech
2. West Virginia Organizes a Program to Fight Obesity
3. Indians Add to Rich Diversity of Virginia Tech
4. Virginia Tech. Shooter -Human Rights or Innocent Lives
5. Virginia Tech Shooters Mental Health Records No More Secret
6. Fire Ants are Emerging Nuisance for Virginians
7. Australian Devises Online Game Based on Virginia Tech Shootout
8. Pain Doctor in Virginia Sentenced to Five Years Imprisonment
9. Five Killed by Methane Gas on Virginia Farm
10. Trust In Doctors Can Affect Taking Medications
11. Repeated checking causes memory distrust
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... A new study provides welcome news for patients ... (VTE). , The condition is estimated to impact ... when an abnormal clot forms in a vein and ... In some cases, the clot may detach from its ... the lungs, causing a potentially fatal condition known as ...
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
(Date:12/5/2009)... This Type of Blood Cancer Is Most Challenging-- ... Pediatric oncologists have identified specific genes, dubbed partner genes, ... form of leukemia in infants. By more accurately defining ... infants may benefit from particular treatments. ,, Oncologists ...
(Date:12/5/2009)... Technology Center helps companies develop and test their cleaning processes. The ... variety of industries and solve problems for customers relating to cleaning ... ... 5, 2009 -- Midbrook, Inc , a Jackson, MI-based company, ...
(Date:12/4/2009)... Varian Medical Systems (NYSE: VAR ) announced ... 2010 Annual Meeting of Stockholders for February 11, 2010 with ... be held at the Crowne Plaza Cabana Hotel, 4290 El ... The meeting will be webcast by Thomson Financial and can ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
... - Exhibits Growth In All Existing Markets -, ... Bulletin Board: PMQC, PMQCU, PMQCW), the third largest long-term ... served. The,Company experienced growth across all four of its ... in the New York City,metropolitan area, as well as ...
... HCA Inc. announced,today that it had commenced a ... aggregate principal amount of its outstanding debt. The series,of ... offer (the "Notes"),are listed in the table below with ... conditions of the tender offer are described in an,Offer ...
... novel drug designed to lessen muscle damage from a heart ... Research Institute. Results of the study, available online and to ... Circulation, reflect the first time the drug has been tested ... the activity of an enzyme called delta protein kinase C ...
... CHAPEL HILL, N.C., Feb. 7 Selecting and ... a new,challenge for marketing leaders at pharmas and ... share similar,structure, composition, and responsibilities -- all detailed ... Best Practices, LLC., According to research findings, ...
... on Exercise (ACE) Research Proves Dance Dance ... Revolution (DDR) Can Be a Tremendous Workout, SAN DIEGO, ... that eliminate conventional hand controllers in favor of more,full-body interaction, ... to the test., The ACE commissioned research out of ...
... Brings Leading Clean Indoor Air and Health Advocates Together ... Indoor Air Quality, SOUTHBOROUGH, Mass., Feb. 7 Most ... did you know the Environmental,Protection Agency says levels of indoor ... occasionally even 100 times higher -- than outdoor air,pollution levels? ...
Other Medicine News:Health News:Chem Rx Surpasses 65,000 Residents Served 2Health News:HCA Announces Cash Debt Tender Offer 2Health News:HCA Announces Cash Debt Tender Offer 3Health News:HCA Announces Cash Debt Tender Offer 4Health News:HCA Announces Cash Debt Tender Offer 5Health News:HCA Announces Cash Debt Tender Offer 6Health News:Novel compound may lessen heart attack damage 2Health News:Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams 2Health News:Can a Video Game Make Your Kids More Fit? 2Health News:February is Designated as 'National Care About Your Indoor Air' Month 2Health News:February is Designated as 'National Care About Your Indoor Air' Month 3Health News:February is Designated as 'National Care About Your Indoor Air' Month 4
(Date:12/6/2009)... Korea, Dec. 6 RNL Bio Co., ... specialized in adult stem cell therapeutics announced today ... Sclerosis improved tremendously after receiving stem cell treatment. ... autoimmune disease that affects the central nervous system ... is a disease in which the nerves of ...
(Date:12/4/2009)... Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) ... of schizophrenia and manic or mixed episodes associated with ... ,, The updated Zyprexa label states that clinicians ... gain and hyperlipidemia in adolescents compared to adults and ...
(Date:12/4/2009)... Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, ... chapter of the American Red Cross are hard at ... that they endure that could potentially put Philadelphia,s blood ... on strike and set up a picket line yesterday ...
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Guidelines Delay Start of Mammograms to Age 50 Then Every Other Year 61475 1Guidelines Delay Start of Mammograms to Age 50 Then Every Other Year 61475 2Guidelines Delay Start of Mammograms to Age 50 Then Every Other Year 61475 3Guidelines Delay Start of Mammograms to Age 50 Then Every Other Year 61475 4Survey Finds AARP Members Back Health Care Reform Legislation 61472 1Survey Finds AARP Members Back Health Care Reform Legislation 61472 2Shengtai Pharmaceutical Inc Reports First Quarter Fiscal Year 2010 Financial Results 61469 1Shengtai Pharmaceutical Inc Reports First Quarter Fiscal Year 2010 Financial Results 61469 2Shengtai Pharmaceutical Inc Reports First Quarter Fiscal Year 2010 Financial Results 61469 3Shengtai Pharmaceutical Inc Reports First Quarter Fiscal Year 2010 Financial Results 61469 4Shengtai Pharmaceutical Inc Reports First Quarter Fiscal Year 2010 Financial Results 61469 5
Double bent ends prevent wire from catching when pushed forward. Designed for use with the Castroviejo Snare (E3675). Package of 12 stainless steel wires. Overall length 4.3 inches....
Replacement snares for the E3525. 3 per package....
... with the E3671 twisted snare wires. The wire ... and the loop can be stopped at any ... the loop can be slipped down the nerve ... inches. Comes with one package of E3671 twisted ...
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Medicine Products: